Document type

Article

Version

Published version

Publication date

Publication license

cc-by (c) Santín Cerezales, Miguel et al., 2020
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/178095

Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis: Case report and review

Journal Title

Director/Tutor

Additional contribution

Journal ISSN

Volume Title

Abstract

Rationale: Paradoxical reaction/immune reconstitution inflammatory syndrome is common in patients with central nervous system tuberculosis. Management relies on high-dose corticosteroids and surgery when feasible. Patient concern: We describe 2 cases of HIV-negative patients with corticosteroid-refractory paradoxical reactions of central nervous system tuberculosis. Diagnoses: The 2 patients experienced clinical impairment shortly after starting therapy for TB, and magnetic resonance imaging showed the presence of tuberculomas, leading to the diagnosis of a paradoxical reaction. Interventions: We added infliximab, an anti-tumor necrosis factor (TNF)-alpha monoclonal antibody, to the dexamethasone. Outcomes: Both patients had favorable outcomes, 1 achieving full recovery but 1 suffering neurologic sequelae. Lessons: Clinicians should be aware of the risk of paradoxical reactions/immune reconstitution inflammatory syndrome when treating patients with tuberculosis of the central nervous system and should consider the prompt anti-TNF-α agents in cases not responding to corticosteroids.

Subject (English)

Citation

Citation

SANTÍN CEREZALES, Miguel, et al. Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis: Case report and review. Medicine. 2020. Vol. 99, num. 43, pags. e22626. ISSN 0025-7974. [consulted: 14 of October of 2026]. Available at: https://hdl.handle.net/2445/178095

Export metadata

JSON - METS

Share record